Complete Conference Management San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians 2025

Complete Conference Management San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians 2025

 Include: 31 videos + 26 pdfs, size: 9.51 GB

Target Audience: cardiologists, internists, primary care physicians

 Information:

The 25th Annual San Diego Heart Failure Winter Symposium – New Strategies for Detection, Prevention and Treatment of Heart Failure. This year’s meeting will provide a comprehensive overview of strategies for detecting, preventing and treating heart failure. The talks, panel discussions and case presentations will focus on best practices and recent guideline recommendations as interpreted through the eyes of a renowned faculty.

Throughout the two days, the faculty will provide expert insight and personal experience as they discuss the full range of management options that are available for patients throughout the spectrum of heart failure, ranging from Stage A (asymptomatic patients with risk factors) all the way to Stage D heart failure (highly symptomatic end-stage patients). New approaches for diagnosing heart failure and identifying specific groups of patients that require special management considerations (such as amyloid, hypertrophic and genetic cardiomyopathies) will be highlighted, rationale for guideline directed medical therapies (GDMTs) will be reviewed and strategies for successful implementation will be presented.

The Symposium combines didactic talks, panel discussions, case presentations and patient perspectives to provide a full and balanced overview of relevant management issues. The four highly focused sessions that comprise this year’s Symposium will cover topics related to Populations and Patients at Risk (Session I), Amyloid Heart Disease, Infiltrative Heart Disease, Hypertrophic and Other Forms of Inherited Cardiomyopathy (Session II), Identifying and Treating Heart Failure (Session III), Cardiogenic Shock, Percutaneous Devices to Support Cardiac Function, Emerging Strategies for Preventing Sudden Cardiac Death and Advances in Catheter Based Treatment of Atrial Fibrillation and Valvular Disease (Session IV).

During each session, the audience will have an opportunity to comment on the talks and question the faculty on their thoughts about the best approaches for patient management. Our goal, as always, is to provide cutting edge information in a format that will enhance adaption of the knowledge that is gained into clinical practice. 

Learning Objectives

At the conclusion of this activity, participants should be able to:

1. Summarize current and emerging treatments available for preventing and treating heart failure and provide information to help in the selection of the most effective choices in individual patients.
2. Review strategies for implementing medical and device therapies that will lead to improved outcomes in heart failure patients.
3. Define how specific populations including minorities, women and the elderly respond to various approaches to treating risk factors and heart failure.

Target Audience

This course is designed for cardiologists, internists, primary care physicians, nurses, PA’s, PharmD’s and all other allied healthcare professionals with an interest in heart failure.

Topics:

• 01 Identifying Patients at Risk for Developing Heart Failure
• 02 Using SGLT inhibitors to Prevent CV Disease and Heart Failure
• 03 GLP-1 Agonists for Reducing Weight, Preventing CV Disease and Treating Heart Failure
• 04 Identifying and Treating Patients with Dyslipidemia
• 05 Use of Non-Steroidal MRAs To Prevent CV Disease, CKD and Heart Failure
• 06 Identifying Patients at Risk for Cardiac Toxicity from Chemotherapy – Update on How to Monitor and Preventive Strategies
• 07 Reducing Cardiovascular Risk in Our Patients- Case Presentation and Panel Discussion
• 08 Recognizing and Treating Patients with Amyloidosis
• 09 Cardiac Myosin Inhibitors and Other New Treatment Options for Patients with Hypertrophic Cardiomyopathy
• 10 Identifying and Treating Sarcoidosis and Other Infiltrative Diseases That Cause Heart Failure
• 11 Gene Therapy for Monogenic Causes of Heart Failure and Other Cardiovascular Disease
• 12 Pulmonary Arterial Hypertension (PAH)
• 13 Heart Failure Management in Adult Congenital Heart Disease
• 14 Peripartum Cardiomyopathy
• 15 Case Presentation and Panel Discussion
• 16 Coffee and Master Class on Physical Diagnosis
• 17 Monitoring Devices To Identify and Treat Congestion
• 18 Treating Patients with HFrEF-The Four Pillars of Therapy
• 19 Adjunctive Medical Therapy for Treating Patients with HFrEF
• 20 Treating Patients with HFpEF – How Do the Experts Do It
• 21 Using Biomarkers To Identify and Manage Heart Failure
• 22 Novel Approaches for Recognizing and Treating Congestion
• 23 How to Talk So Patients with Listen How to Listen So Patients Will Talk
• 24 Case Presentation
• 25 Identifying and Treating Cardiogenic Shock
• 26 Percutaneous Devices for Temporary Support of Cardiac Function
• 27 Catheter Based Treatments of Valvular Heart Disease
• 28 Left Atrial Occlusion Devices for Preventing Thromboemboli Complications of Atrial Fibrillation
• 29 Advances in Preventing Sudden Cardiac Death in Patients with Heart Failure
• 30 Stage D Heart Failure and Available Treatment Options to Improve Outcomes
• 30 Stage D Heart Failure and Available Treatment Options to Improve Outcomes
• 31 Palliative and Hospice Care for Patients with Advanced Heart Failure
• SDHF Winter Symposium 2025.pdf